Product
HZN-457
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase 1 Randomized, Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HZN-457 in Healthy VolunteersStatus: Completed, Estimated PCD: 2023-08-09